Literature DB >> 29583036

The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behçet's disease.

Akiko Suwa1, Nobuyuki Horita2, Takehito Ishido1, Masaki Takeuchi1, Tatsukata Kawagoe1, Etsuko Shibuya1, Takahiro Yamane1, Takahiko Hayashi1, Akira Meguro1, Mizuho Ishido1, Kaoru Minegishi3, Ryusuke Yoshimi3, Yohei Kirino3, Shingo Kato4, Jun Arimoto4, Takeshi Fukumoto5, Yoshiaki Ishigatsubo6, Michiko Kurosawa7, Takeshi Kaneko2, Mitsuhiro Takeno8, Nobuhisa Mizuki1.   

Abstract

OBJECTIVES: This study aimed to identify patients with high-probability of ocular involvement of Behçet's disease (BD).
METHODS: The Japanese Ministry of Health, Labour and Welfare provided dataset of ongoing nationwide BD registration project. A patient who had confirmed BD and who was suspected to have BD was registered. We mainly analyzed newly registered patients who had the data for all demographic and diagnostic parameters regardless of fulfilment of any diagnostic criteria.
RESULTS: Among 3213 patients with confirmed or possible BD, 1382 (43.0%) were men and 1831 (57.0%) were women with a median age of 38 years (interquartile range (IQR) 30-49 years). The median duration between onset and registration was 0 year (IQR 0-3). A binomial multivariable logistic regression analysis revealed that being female (odds ratio (OR) 0.63, 95% confidence interval (CI) 0.53-0.75, p < .001), duration since onset (OR 1.33 per 10 years, 95% CI 1.18-1.51, p < .001), genital ulceration (OR 0.28, 95% CI 0.23-0.34, p < .001), and gastrointestinal symptoms (OR 0.36, 95% CI 0.30-0.44, p < .001) were related to the ocular lesion. Analyses based on data of 2800 patients who satisfied International criteria of BD, age-, sex-, duration-based subgroup analyses, analyses targeting iridocyclitis and retino-uveitis, and analysis including patients with missing data confirmed that the four factors were associated with the probability of eye involvement.
CONCLUSION: The ocular involvement did not accompany with genital ulcer or gastrointestinal symptoms at the early stage of BD.

Entities:  

Keywords:  Behçet’s syndrome; epidemiology; surveys and questionnaires; uveitis

Mesh:

Year:  2018        PMID: 29583036     DOI: 10.1080/14397595.2018.1457424

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  5 in total

1.  Behçet's syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics.

Authors:  Jurgen Sota; Donato Rigante; Giacomo Emmi; Giuseppe Lopalco; Ida Orlando; Gian Marco Tosi; Bruno Frediani; Antonio Vitale; Silvana Guerriero; Florenzo Iannone; Lorenzo Vannozzi; Claudia Fabiani; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2020-02-01       Impact factor: 3.397

Review 2.  Noninfectious uveitis in the Asia-Pacific region.

Authors:  Yung-Ray Hsu; Jerry Chien-Chieh Huang; Shih-Hwa Chiou; De-Kuang Hwang; Yong Tao; Toshikatsu Kaburaki; Christopher Seungkyu Lee; Tai-Chi Lin; Chih-Chien Hsu
Journal:  Eye (Lond)       Date:  2018-10-15       Impact factor: 3.775

3.  Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet's disease in Japan.

Authors:  Yutaro Soejima; Yohei Kirino; Mitsuhiro Takeno; Michiko Kurosawa; Masaki Takeuchi; Ryusuke Yoshimi; Yumiko Sugiyama; Shigeru Ohno; Yukiko Asami; Akiko Sekiguchi; Toshihisa Igarashi; Shohei Nagaoka; Yoshiaki Ishigatsubo; Hideaki Nakajima; Nobuhisa Mizuki
Journal:  Arthritis Res Ther       Date:  2021-02-01       Impact factor: 5.156

4.  Cluster analysis of phenotypes of patients with Behçet's syndrome: a large cohort study from a referral center in China.

Authors:  Jun Zou; Jian-Feng Luo; Yan Shen; Jian-Fei Cai; Jian-Long Guan
Journal:  Arthritis Res Ther       Date:  2021-01-30       Impact factor: 5.156

5.  Succinivibrionaceae is dominant family in fecal microbiota of Behçet's Syndrome patients with uveitis.

Authors:  Duygu Tecer; Feride Gogus; Ayse Kalkanci; Merve Erdogan; Murat Hasanreisoglu; Çagri Ergin; Tarkan Karakan; Ramazan Kozan; Seda Coban; Kadir Serdar Diker
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.